print

Preview & Print

Properties

Preview & Print

Properties

Steps (7) arrow_drop_up arrow_drop_down
Obtain license to operate as a pharmaceutical manufacturer  (7) expand_more expand_less

arrow_drop_up arrow_drop_down
Summary of the procedure

Institutions involved 2 expand_more expand_less

National drug authority (x 5)
Stanbic bank

Results 2 expand_more expand_less

Manufacturing licence
Certificate of good manufacturing practices

Required Documents expand_more expand_less

Certificate of incorporation
Commitment letter of the pharmacist
Site master plan (x 2)
Form 7
Sketch plan
NDA invoice
Proof of payment
Premises
National identity card

Cost expand_more expand_less

UGX 0

Total Duration 8 d - 19 d expand_more expand_less

  Min. Max.
Total time (sum): 8 d 19 d
of which:
Waiting time in queue (sum): 5mn 15mn
Attention at counter: 55mn 2h. 50mn
Waiting time until next step (sum): 8 d 18 d

Laws 4 expand_more expand_less

Drug importation and exportation regulation Drug importation and exportation regulation
  Section  21
National drug policy and authority act cap 2016 National Drug Policy and Authority Act CAP 2016
The National Drug Policy and Authority (certificate of suitability of premises) Regulations, 2014. The National Drug Policy and Authority (certificate of suitability of premises) Regulations, 2014.
  Sections 5, 6, 8-30
The National drug policy and Authority Drug fees regulation 2014 The National drug policy and Authority Drug fees regulation 2014
  Article Reg 2
Powered by eRegulations ©, a content management system developed by UNCTAD's Business Facilitation Program and licensed under Creative Commons License